Big Ideas program seeks applications
The Big Ideas 2021-2022 competition is open. The program provides opportunities for collaborative teams to develop innovations in informatics and health-care delivery The deadline to submit a letter of intent is March 29.
International Alzheimer’s clinical trial to test tau drugs
A worldwide clinical trial aimed at finding treatments for Alzheimer’s disease has expanded to include investigational drugs targeting a harmful form of the brain protein tau. The trial is led by Washington University School of Medicine.
Foodborne fungus impairs intestinal wound healing in Crohn’s disease
A foodborne fungus that is harmless to most people exacerbates gastrointestinal symptoms in people with Crohn’s disease by preventing intestinal ulcers from healing, according to a new study from the School of Medicine and the Cleveland Clinic.
Joining forces to tackle a public health challenge
Researchers at Washington University School of Medicine in St. Louis and the Brown School are working together to decrease the burden of COVID-19 on a vulnerable group. The School of Medicine will offer 50,000 saliva tests for the SARS-CoV-2 virus to students, teachers, and staff in the six special education schools operated by the Special School District of St. […]
Promising role for whole genome sequencing in guiding blood cancer treatment
A new study from the School of Medicine shows that whole genome sequencing is at least as accurate — and often better than — conventional genetic tests that help determine the treatment for a patient’s blood cancer.
Folding@home quickly pivots to fight COVID-19
When the crowdsourced supercomputing project Folding@home first announced a shift to coronavirus research and asked for new volunteers to run its software and expand its computing capacity, organizations and citizen scientists from all walks of life heeded the call. Now, about four months later, the number of volunteers has increased a hundredfold. Based at Washington University School of […]
Immune cell implicated in development of lung disease following viral infection
Scientists at the School of Medicine have implicated a type of immune cell in the development of chronic lung disease that sometimes is triggered following a respiratory viral infection. The study was published in The Journal of Immunology.
School of Medicine researchers develop COVID-19 nasal vaccine
Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose, and is effective in preventing infection in mice susceptible to the novel coronavirus. The investigators—Michael S. Diamond, MD, PhD the Herbert S. Gasser Professor of Medicine and […]
Clinical trial in children to investigate rare inflammatory disorder linked to COVID-19
Washington University pediatricians who treat patients at St. Louis Children’s Hospital are part of a major research effort to investigate how the novel coronavirus affects children and young adults, including its role in a rare but serious inflammatory syndrome.
Bowman receives grant to study Alzheimer’s disease
Gregory Bowman, associate professor of biochemistry and molecular biophysics at the School of Medicine, received a three-year $1,763,634 grant award from the National Institute on Aging of the National Institutes of Health (NIH) for his research titled “Structural basis for ApoE4-induced Alzheimer’s disease.”
View More Stories